Cardiac Remodeling: Clinical Trials

8 trials for Cardiac Remodeling, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 not yet recruiting, 1 active not recruiting, 1 recruiting. 2 Phase 2, 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 32Completed 1, Not yet recruiting 1
Phase 41Not yet recruiting 1

Follow Cardiac Remodeling: new trials by email Literature Review of Cardiac Remodeling trials Research Report on Cardiac Remodeling

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hormone thERapy Effects on BRAin-HEART Health During the Menopausal Transition
Transdermal estradiol, Standard of care - non hormonal - Menopause, Perimenopause
Phase 4Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre1002026-11-012026-07-29
Baxdrostat and Ventricular Remodeling
Baxdrostat, Placebo - Cardiac Remodeling
Phase 3Not yet recruitingSubodh Verma2862026-06-302026-06-17
Cardiac Morphology and Function in Individuals With Autonomic Dysreflexia
Autonomic Dysreflexia, Spinal Cord Injuries and Disorders (SCI/D)
RecruitingSwiss Paraplegic Research, Nottwil482026-06-012026-08-27
Effect of Genetic Polymorphism on the Clinical Outcome to SGLT2 Inhibitors in Heart Failure Patients
SGLT2 inhibitor (Dapagliflozin 10mg) - Heart Failure - NYHA II - IV, Cardiac Fibrosis
Active not recruitingAin Shams University2002023-11-222025-03-30
Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction
Paroxetine, Placebo oral capsule - Cardiac Remodeling, Myocardial Infarction
Phase 2CompletedInsel Gruppe AG, University Hospital Bern502017-10-262022-06-01
AI-ECG for Time-Resolved Prediction of HFrEF
Heart Failure, Heart Failure With Reduced Ejection Fraction
CompletedShanghai Zhongshan Hospital2867092014-02-012026-04-09
Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis
Metoprolol succinate, placebo - Cirrhosis, Cirrhotic Cardiomyopathy
Phase 3CompletedUniversity of Sao Paulo1252012-01-012014-09-11
Post-Myocardial Infarction Remodeling Prevention Therapy
Single Site Pacing, Dual Site Pacing - Acute Myocardial Infarction, Pacing Therapy
Phase 2CompletedMedtronic Cardiac Rhythm and Heart Failure1292010-12-012016-12-15

Narrower conditions

Heart Failure (2)  ·  Autonomic Dysreflexia (1)  ·  Cardiomyopathies (1)  ·  Disease (1)  ·  Fibrosis (1)  ·  Myocardial Infarction (1)  ·  Spinal Cord Injuries (1)  ·  Ventricular Dysfunction, Left (1)  ·  Ventricular Remodeling (1)

Broader conditions

Cardiovascular Diseases (4)  ·  Heart Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Pathologic Processes (3)  ·  Autonomic Nervous System Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Myocardial Ischemia (1)  ·  Necrosis (1)  ·  Nervous System Diseases (1)  ·  Pathological Conditions, Anatomical (1)  ·  Spinal Cord Diseases (1)  ·  Trauma, Nervous System (1)  ·  Vascular Diseases (1)

Interventions

Estradiol (1)  ·  Gabapentin (1)  ·  Gels (1)  ·  Metoprolol (1)  ·  Paroxetine (1)  ·  Selective Serotonin Reuptake Inhibitors (1)  ·  Sodium-Glucose Transporter 2 Inhibitors (1)  ·  dapagliflozin (1)  ·  fezolinetant (1)  ·  oxybutynin (1)

Sponsors

Ain Shams University (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Medtronic Cardiac Rhythm and Heart Failure (1)  ·  Shanghai Zhongshan Hospital (1)  ·  Subodh Verma (1)  ·  Swiss Paraplegic Research, Nottwil (1)  ·  University of Sao Paulo (1)

Countries

Switzerland (2)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  Egypt (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Saudi Arabia (1)  ·  Slovakia (1)  ·  United States (1)

Top investigators

Angel Leon, MD (1)  ·  Bassem Zarif, MD (1)  ·  Fernando Bacal, MD, PhD (1)  ·  Gregg Stone, MD (1)  ·  Subodh Verma, MD, PhD (1)  ·  Thomas Pilgrim, MD (1)

Results publications

PMID 26321236, PMID 34259826, PMID 36000427

NIH funding

2016 (1)